**
In a troubling reflection of the current state of the NHS, Chloe Keys, a 26-year-old from Manchester, has shared her harrowing experience of suffering from debilitating symptoms caused by uterine fibroids. After enduring excruciating pain and heavy bleeding for years, she felt compelled to seek private healthcare, citing long NHS waiting lists and inadequate support. Her story highlights a pressing issue within women’s health services and underscores the urgent need for reform.
A Life Dominated by Pain
Diagnosed with Polyendocrine Metabolic Ovarian Syndrome (PMOS) since her teenage years, Ms Keys discovered the presence of large fibroids in 2022. These non-cancerous growths led to severely heavy menstrual periods, frequent haemorrhaging, and debilitating symptoms that included extreme stomach pain, fatigue, and significant mood fluctuations. Describing her ordeal, she recounted a distressing incident while on holiday in Seville, where she “left a trail of blood” due to her condition.
Following surgery to remove the fibroid, which she described as being “the size of a large mango,” Ms Keys reflected on the impact these health issues had on her life. “I was a shell of a human being for half the month during my period,” she revealed. “I was housebound, severely anaemic, and heavily depressed. No one was listening; I was left with no choice but to go private.”
Frustrations with the NHS
Facing multiple cancellations and rescheduled appointments, Ms Keys’ frustration with the NHS reached a peak during a visit when she learned her consultant had left, despite her long wait for an appointment. “I waited nine months for this appointment, and they cancelled it while I was sat there in the waiting room,” she said, recalling the emotional toll it took on her.
While her consultant suggested an oral treatment called Ryeqo to shrink the fibroids, Ms Keys was apprehensive about the side effects, which included entering a state of medical menopause. She sought alternative options, including surgery, but felt she was met with resistance from the healthcare providers.
Widespread Concerns Among Women
Ms Keys’ concerns are echoed by findings from a recent survey by Hertility, a women’s health platform, which revealed that over 90 per cent of women felt their reproductive health concerns were not taken seriously by healthcare professionals. This lack of responsiveness is not merely anecdotal; it reflects a broader trend that many women face in navigating health issues.
Deirdre O’Neill, co-founder of Hertility, stated: “Healthcare should be preventative, personalised, and precision-led. Women deserve better than a system that asks them to wait for answers.” The survey also highlighted that two-thirds of female employees had been dismissed regarding their fatigue and anxiety, only to later receive clinical diagnoses.
Breaking the Silence on Women’s Health Issues
In the corporate realm, Ms Keys expressed the stigma surrounding women’s health that she has encountered. She described feeling compelled to hide her condition to maintain professionalism, often attending work meetings while managing heavy menstrual bleeding. “I’m sick of having to leave your health conditions at the door,” she stated, stressing the need for more open conversations around women’s health issues in the workplace.
In light of her experiences, Ms Keys is advocating for the introduction of external educators to train managers on how to better support female employees dealing with health conditions.
The NHS Response
In response to Ms Keys’ experiences, a spokesperson for Manchester University Foundation Trust acknowledged the frustration caused by appointment cancellations and reassured patients that they are continually reviewing waiting lists to prioritise care. They noted that 80 per cent of patients seeking gynaecological treatment would be seen within 46 weeks, but this still falls short of patient expectations.
Currently, over seven million people in the UK are on waiting lists for non-emergency procedures, prompting calls for immediate action to meet government targets that stipulate 92 per cent of patients should wait no longer than 18 weeks for treatment.
Why it Matters
The challenges faced by Chloe Keys are emblematic of systemic issues within women’s healthcare in the UK. Her journey underscores the urgent need for comprehensive reform in the NHS, particularly in how women’s health concerns are addressed. The stigma surrounding these issues must be dismantled, allowing for more open dialogue and timely medical intervention. As awareness around conditions like fibroids grows, it is imperative that healthcare systems evolve to provide the necessary support and care that women like Ms Keys rightfully deserve.